Download Free Sample
Author
Muni Kumar Meravath is a seasoned Healthcare Market Research Analyst with over 6 years of experience in the healthc.....
Cardiovascular implants Market: By Type Device), By End User and By Geography
Cardiovascular implants Market: By Type Device), By End User and By Geography
Cardiovascular implants Market is expected to grow at a CAGR of 7% during the forecast period 2023 to 2029. Cardiovascular implants have been brought into clinical practice for an expansive range of signs. Cardiovascular implants can be embedded in relatively every area all through the cardiovascular framework. Adjacent to the careful course, numerous different ways and strategies have been produced for acquiring the embed to its predetermination the human body. Heart specialists, vessel specialists, neurosurgeons, radiologists, cardiologists and pediatric cardiologists routinely perform implantations of a huge assortment of gadgets into veins or into the heart. Global cardiovascular implants market expected to grow at significant rate owing to increase in cases heart failure around the world. Cardiovascular implants are the one of the promising treatment option for the heart failure patients. Market has many of the players and comprising of huge competition among them. Companies are collaborating to other technological companies in development of the new and innovative products for company market growth. In 2017, Abbott has secured U.S. Food and Drug Administration (FDA) clearance for the Confirm Rx Insertable Cardiac Monitor (ICM), the world's first and only smartphone compatible ICM designed to help physicians remotely identify cardiac arrhythmias
Study Period
2024-2030Base Year
2023CAGR
7%Largest Market
North AmericaFastest Growing Market
Europe
Global cardiovascular implants market is driven by growing aging population who are very susceptible to the heart related diseases and technological developments in cardiovascular implants that minimizing the chances of infection and improved efficiency of devices Furthermore, cardiovascular implants are one of the more reliable and efficient options for the heart failure management. However, factors such as availability of alternative treatment options expected to hinder the market growth. Furthermore chances of infection, high cost of cardiovascular implants and stringent regulatory procedures may act as restraints for the growth of global cardiovascular implants market over the forecast period.
Geographically cardiovascular implants market is segmented as Latin America, North America, Asia- Pacific, The Middle East & Africa and Europe. North America is expected to be major market for cardiovascular implants owing to factors such as growing awareness in patients about the cardiovascular implants, well established healthcare infrastructure and favourable reimbursement policies. Europe cardiovascular implants market expected to grow at significant rates owing to increase in growing heart related diseases and rising geriatric population. Asia Pacific cardiovascular implants market expected to grow at notable rates owing to developing healthcare infrastructure and growing awareness in patients.
Latin America
Europe
Asia Pacific
Middle East
North America
|
Report Benchmarks |
Details |
|
Report Study Period |
2024-2030 |
|
Market CAGR |
7% |
|
By Type |
|
|
By End User |
|
|
BY By Region |
|
Download Free Sample Report
The key segments covered in the Cardiovascular implants Market are: by type, by end user
The Cardiovascular implants Market has been classified into North America, Asia Pacific, Europe, Latin America, Middle East and Africa, and the rest of MEA.
Europe is the fastest-growing for Cardiovascular implants Market
| 1.Executive Summary |
| 2.Global Cardiovascular implants Market Introduction |
| 2.1.Global Cardiovascular implants Market - Taxonomy |
| 2.2.Global Cardiovascular implants Market - Definitions |
| 2.2.1.Type |
| 2.2.2.End User |
| 2.2.3.Region |
| 3.Global Cardiovascular implants Market Dynamics |
| 3.1. Drivers |
| 3.2. Restraints |
| 3.3. Opportunities/Unmet Needs of the Market |
| 3.4. Trends |
| 3.5. Product Landscape |
| 3.6. New Product Launches |
| 3.7. Impact of COVID 19 on Market |
| 4.Global Cardiovascular implants Market Analysis, 2018-2022 and Forecast 2023-2029 |
| 4.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million) |
| 4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) |
| 4.3. Market Opportunity Analysis |
| 5.Global Cardiovascular implants Market By Type, 2018-2022 and Forecast 2023-2029 (Sales Value USD Million) |
| 5.1. Coronary Stents, Peripheral Stents |
| 5.1.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million) |
| 5.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.1.3. Market Opportunity Analysis |
| 5.2. Heart Valves |
| 5.2.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million) |
| 5.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.2.3. Market Opportunity Analysis |
| 5.3. Implanted Cardiac Pacemakers |
| 5.3.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million) |
| 5.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.3.3. Market Opportunity Analysis |
| 5.4. Implantable Cardioverter Defibrillator |
| 5.4.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million) |
| 5.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.4.3. Market Opportunity Analysis |
| 5.5. Cardiac Resynchronization Therapy (CRT) Device |
| 5.5.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million) |
| 5.5.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.5.3. Market Opportunity Analysis |
| 6.Global Cardiovascular implants Market By End User, 2018-2022 and Forecast 2023-2029 (Sales Value USD Million) |
| 6.1. Hospitals |
| 6.1.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million) |
| 6.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 6.1.3. Market Opportunity Analysis |
| 6.2. Ambulatory Surgical Centres |
| 6.2.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million) |
| 6.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 6.2.3. Market Opportunity Analysis |
| 6.3. Cardiac Centers |
| 6.3.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million) |
| 6.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 6.3.3. Market Opportunity Analysis |
| 7.Global Cardiovascular implants Market By Region, 2018-2022 and Forecast 2023-2029 (Sales Value USD Million) |
| 7.1. North America |
| 7.1.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million) |
| 7.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 7.1.3. Market Opportunity Analysis |
| 7.2. Europe |
| 7.2.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million) |
| 7.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 7.2.3. Market Opportunity Analysis |
| 7.3. Asia Pacific (APAC) |
| 7.3.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million) |
| 7.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 7.3.3. Market Opportunity Analysis |
| 7.4. Middle East and Africa (MEA) |
| 7.4.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million) |
| 7.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 7.4.3. Market Opportunity Analysis |
| 7.5. Latin America |
| 7.5.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million) |
| 7.5.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 7.5.3. Market Opportunity Analysis |
| 8.North America Cardiovascular implants Market ,2018-2022 and Forecast 2023-2029 (Sales Value USD Million) |
| 8.1. Type Analysis 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 8.1.1.Coronary Stents, Peripheral Stents |
| 8.1.2.Heart Valves |
| 8.1.3.Implanted Cardiac Pacemakers |
| 8.1.4.Implantable Cardioverter Defibrillator |
| 8.1.5.Cardiac Resynchronization Therapy (CRT) Device |
| 8.2. End User Analysis 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 8.2.1.Hospitals |
| 8.2.2.Ambulatory Surgical Centres |
| 8.2.3.Cardiac Centers |
| 8.3. Country Analysis 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 8.3.1.United States of America (USA) |
| 8.3.2.Canada |
| 9.Europe Cardiovascular implants Market ,2018-2022 and Forecast 2023-2029 (Sales Value USD Million) |
| 9.1. Type Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 9.1.1.Coronary Stents, Peripheral Stents |
| 9.1.2.Heart Valves |
| 9.1.3.Implanted Cardiac Pacemakers |
| 9.1.4.Implantable Cardioverter Defibrillator |
| 9.1.5.Cardiac Resynchronization Therapy (CRT) Device |
| 9.2. End User Analysis 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 9.2.1.Hospitals |
| 9.2.2.Ambulatory Surgical Centres |
| 9.2.3.Cardiac Centers |
| 9.3. Country Analysis 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 9.3.1.Germany |
| 9.3.2.France |
| 9.3.3.Italy |
| 9.3.4.United Kingdom (UK) |
| 9.3.5.Spain |
| 9.3.6.Rest of EU |
| 10.Asia Pacific (APAC) Cardiovascular implants Market ,2018-2022 and Forecast 2023-2029 (Sales Value USD Million) |
| 10.1. Type Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 10.1.1.Coronary Stents, Peripheral Stents |
| 10.1.2.Heart Valves |
| 10.1.3.Implanted Cardiac Pacemakers |
| 10.1.4.Implantable Cardioverter Defibrillator |
| 10.1.5.Cardiac Resynchronization Therapy (CRT) Device |
| 10.2. End User Analysis 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 10.2.1.Hospitals |
| 10.2.2.Ambulatory Surgical Centres |
| 10.2.3.Cardiac Centers |
| 10.3. Country Analysis 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 10.3.1.China |
| 10.3.2.India |
| 10.3.3.Australia and New Zealand (ANZ) |
| 10.3.4.Japan |
| 10.3.5.Rest of APAC |
| 11.Middle East and Africa (MEA) Cardiovascular implants Market ,2018-2022 and Forecast 2023-2029 (Sales Value USD Million) |
| 11.1. Type Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 11.1.1.Coronary Stents, Peripheral Stents |
| 11.1.2.Heart Valves |
| 11.1.3.Implanted Cardiac Pacemakers |
| 11.1.4.Implantable Cardioverter Defibrillator |
| 11.1.5.Cardiac Resynchronization Therapy (CRT) Device |
| 11.2. End User Analysis 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 11.2.1.Hospitals |
| 11.2.2.Ambulatory Surgical Centres |
| 11.2.3.Cardiac Centers |
| 11.3. Country Analysis 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 11.3.1.GCC Countries |
| 11.3.2.South Africa |
| 11.3.3.Rest of MEA |
| 12.Latin America Cardiovascular implants Market ,2018-2022 and Forecast 2023-2029 (Sales Value USD Million) |
| 12.1. Type Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 12.1.1.Coronary Stents, Peripheral Stents |
| 12.1.2.Heart Valves |
| 12.1.3.Implanted Cardiac Pacemakers |
| 12.1.4.Implantable Cardioverter Defibrillator |
| 12.1.5.Cardiac Resynchronization Therapy (CRT) Device |
| 12.2. End User Analysis 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 12.2.1.Hospitals |
| 12.2.2.Ambulatory Surgical Centres |
| 12.2.3.Cardiac Centers |
| 12.3. Country Analysis 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 12.3.1.Brazil |
| 12.3.2.Mexico |
| 12.3.3.Rest of LA |
| 13. Competition Landscape |
| 13.1. Market Player Profiles (Introduction, Brand/Product Sales, Financial Analysis, Product Offerings, Key Developments, Collaborations, M & A, Strategies, and SWOT Analysis) |
| 13.2.1.Calon Cardio-Technology Ltd. (U.K. |
| 13.2.2.SynCardia Systems, Inc. (U.S.) |
| 13.2.3.Medtronic (U.S.) |
| 13.2.4.Berlin Heart GmbH (Germany) |
| 13.2.5.CHF Solutions, Inc. (U.S.) |
| 13.2.6.Teleflex Incorporated (U.S.) |
| 13.2.7.MAQUET GmbH & Co. (Germany) |
| 13.2.8.Abiomed (U.S.) |
| 13.2.9.Abbot Laboratories (U.S.) |
| 14. Research Methodology |
| 15. Appendix and Abbreviations |
Key Market Players
Author
Muni Kumar Meravath is a seasoned Healthcare Market Research Analyst with over 6 years of experience in the healthcare domain, encompassing pharmaceuticals, medical devices, and diagnostics. A graduate in Pharmacy, he possesses a strong foundation in the intricacies of the healthcare sector. He further enhanced his expertise by pursuing an MBA in Pharmaceuticals, equipping him with valuable business acumen. His analytical skills and market insights have contributed to strategic decision-making and enhanced market positioning for various healthcare organizations. Committed to driving innovation and excellence, Muni continues to seek opportunities to improve healthcare delivery through data-driven insights.